COMMERCIALISATION

DXB signs $230M Commercialisation Deal for ~20% of the global market

Next Investors Oct 05, 2023

Our 2021 Biotech Pick of the Year, Dimerix (ASX:DXB) has secured a $230M commercialisation deal with Advanz Pharmaceuticals for its Phase 3 drug targeting FSGS, a deal made before key trial results and a major ~$10.8M upfront payment in cash.

Alexium Delivers 30% Increase in Cash Receipts in December Quarter

Next Investors Jan 29, 2021

Alexium International Group Limited (ASX:AJX) has delivered an impressive result for the December quarter with cash receipts up by approximately 30% to $2.2 million on a quarter-on-quarter basis.

Telix a standout diagnostic and therapeutic radiopharmaceutical play

Finfeed Archived May 19, 2020

Telix Pharmaceuticals Limited (ASX: TLX) has entered into a commercial distribution agreement with US-based Pharmalogic Holdings

YPB makes major breakthrough - now one step closer to commercialisation

Finfeed Archived Sep 12, 2019

YPB Group (ASX:YPB) is one step closer to commercialisation, following the announcement a major technical breakthrough in the development of its Motif Micro technology.

Australia’s top biotechs descend on Queenstown for the 2019 Bioshares Summit

Finfeed Archived Jul 25, 2019

Queenstown, the New Zealand extreme sport mecca, hosts the annual Bioshares Biotech Summit, gathering together some of the best long-standing and emerging biotech companies in the country to talk all things trials, tribulations and potential cures for cancer.

YPB signs MSA with iconic Seppeltsfield Wines

Finfeed Archived Jun 18, 2019

YPB Group Ltd (ASX:YPB) has signed a Master Services Agreement with Seppeltsfield Wines for the supply of YPB’s brand authenticity solutions for select lines.

From the ASX top 200 to SMEs: the 7 most frequent failures by Australian organisations

Finfeed Archived Jun 13, 2019

What are the most frequent audit failures for Australian businesses including ASX 200 businesses down to SMEs?.

Leigh Creek surges 25% as commercialisation nears

Finfeed Archived May 27, 2019

Plenty of promising newsflow since Leigh Creek Energy Ltd (ASX:LCK) released its maiden 2P Reserve on 20 March, 2019 has been reflected in the group’s share price which hit a high of 43 cents in March, up from less than 10 cents in February.

Michele Laghezza: Why the customer is still king at Miele

Finfeed Archived Apr 01, 2019

During his decade long tenure at Miele’s HQ in Italy, Michele Laghezza was the company’s Marketing Director, responsible for overseeing its communications and brand strategy.